跳至主要内容
临床试验/DRKS00006123
DRKS00006123招募中不适用

ADOREG - development and establishment of a nationwide prospective register for Health Services Research in dermatologic oncology - ADOREG

niklinik Essen, Hautklinik0 个研究点目标入组 20,000 人开始时间: 2016年5月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Malignant Melanoma from Stage IIB (Pilotphase)
  • - Epithelial Skin Cancer
  • - Actinic Keratosis

排除标准

  • No sign / confirmation of Malignant Melanoma from Stage IIB, Epithelial Skin Cancers or Actinic Ceratosis

研究者

发起方
niklinik Essen, Hautklinik

相似试验

尚未招募
不适用
The development of a nationwide cooperation system for asthma studies and making guidelines for diagnosis and therapy of asthmaasthma
JPRN-UMIN000036692Kinki Hokuriku Airway disease Conference500
招募中
不适用
eiden Consortium Individual DevelopmentExternalizing behavior problemsbehavioral controlparentingdisciplinesocial competence
NL-OMON24185eiden University, Faculty of Social and Behavioral Sciences1,000
已完成
不适用
Building on success: the sustainability and national feasibility of a community pharmacy intervention to improve the management of asthmaAsthmaRespiratory - Asthma
ACTRN12609000196246nit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania30
进行中(未招募)
1 期
Accelerating the Development and implementation of Personalised Treatments of DNA damage response agents and radiotherapy with and without immunotherapy for head and neck squamous cell cancerHead and neck squamous cell carcinoma (HNSCC)MedDRA version: 21.1Level: PTClassification code 10067821Term: Head and neck cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2020-001034-35-GBniversity of Birmingham80
进行中(未招募)
1 期
Accelerating the development and implementation of DNA damage inhibitor and radiotherapy treatment (with or without immunotherapy) in head and neck squamous cell carcinomaPrimary head and neck squamous cell carcinoma (HNSCC): laryngeal, hypopharyngeal, oropharyngeal cancerCancerMalignant neoplasm of larynx, Malignant neoplasm of hypopharynx, Malignant neoplasm of oropharynx
ISRCTN66274524niversity of Birmingham80